BioSpace News Archive

The American Cancer Society celebrates another year of its signature fundraiser, Relay For Life, with the 2021 season virtual kickoff slated for Thursday, February 4, 2021 at 8 PM EST.

Longevity Acquisition Corporation (NASDAQ: LOAC) (the “Company”), a publicly-traded special purpose acquisition company, announced today that on February 3, 2021 , 4D pharma plc (AIM: DDDD) (“4D pharma”), a pharmaceutical company leading the development of Live Biotherapeutic products (“LBPs”) has announced progress on activities in its development program

CLEW Medical, a leader in AI-powered predictive analytics, today announced that the U.S. Food and Drug Administration (FDA) has given 510(k) clearance and authorized the use of “CLEWICU,” CLEW’s artificial intelligence (AI) based ICU solution, to predict hemodynamic instability in adult patients.

Aruvant Sciences, a private company focused on developing gene therapies for rare diseases, today announced that the European Medicines Agency (EMA) granted Priority Medicines (PRIME) designation to ARU-1801, a one-time investigational gene therapy for sickle cell disease (SCD)

TMRW Life Sciences announces that it has launched the world’s first automated cryo specimen management solution for embryos and eggs used in in vitro fertilization.

Patient empowerment platform, Lyfebulb, and TRIO (Transplant Recipients International Organization) announced today their partnership to provide the transplant community with the support they need during their journey.

Modern Vascular, a pioneering medical group dedicated to preventing amputation through the treatment of Peripheral Artery Disease (PAD), today announced the expansion of its national footprint to 13 clinics with the opening of an office in Richmond, Texas, in Fort Bend County

New portfolio of products includes monitoring solutions and robust analytics software to help ensure product safety and integrity

On 18 February, at 08:00 CET, Swedish Orphan Biovitrum AB will publish its report for the forth quarter and full-year 2020.

Vystar® Corporation has selected Corrie MacColl Limited, a subsidiary of global natural rubber supply chain manager Halcyon Agri, as its exclusive global partner for all aspects of product market development and distribution of patented Vytex® deproteinized latex.